The earnings call presented a mix of strong performance in the consumables and IV systems segments, as well as new product developments, but was significantly impacted by tariff expenses and challenges in the Vital Care segment. The lowering of the guidance range also reflects the ongoing impact of tariffs.

Company Guidance -

Q3 2025

During the ICU Medical Second Quarter 2025 Earnings Conference Call, the company reported Q2 revenue of $544 million, signifying a 2% organic growth, despite a 6% decline when reported due to a joint venture (JV) impact. Consumables and IV Systems showed positive year-over-year growth, with Consumables hitting a record sales quarter. The adjusted EBITDA reached $100 million, and EPS was $2.10. Gross margins exceeded expectations, driven by the JV and favorable foreign exchange. However, tariffs, particularly from Costa Rica, pose a challenge, anticipated to cost $25-$30 million for FY '25, with the company aiming to mitigate these through price increases and cost savings. For the full year, the guidance for adjusted EBITDA was narrowed to $380-$390 million, and adjusted EPS to $6.85-$7.15, reflecting the tariff impacts. The company emphasized continued strategic focus on growth in the Consumables and IV Systems segments, with anticipated record performance in Q3 for these areas.

Strong Consumables Performance

The consumables business grew 4% organically and 3% reported, achieving a record quarter in absolute sales levels driven by new global customer implementations, price improvements, and rapid growth in niche markets.

IV Systems Segment Growth

IV Systems business grew 2% organically and reported, with double-digit LVP growth driven by new installations and strong census for dedicated set utilization.

Adjusted EBITDA and EPS Increase

Adjusted EBITDA for Q2 increased by 10% to $100 million compared to $91 million last year. Adjusted EPS was $2.10, up from $1.56 last year.

Gross Margin Expansion

Adjusted gross margin for Q2 was 40%, showing a 3 percentage point expansion year-over-year and sequentially, largely driven by the deconsolidation of the IV Solutions business.

New Product Developments

Received additional 510(k) clearance for Clave connectors, correlating usage with lower patient infection rates. New submissions for Medfusion 5000 syringe pump and CADD ambulatory pumps have been filed.

ICU Medical (ICUI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ICUI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	1.43 / -	1.59	―	―	―
Aug 07, 2025	2025 (Q2)	1.50 / 2.10	1.56	34.62% (+0.54)
May 08, 2025	2025 (Q1)	1.28 / 1.72	0.96	79.17% (+0.76)
Feb 27, 2025	2024 (Q4)	1.48 / 2.11	1.57	34.39% (+0.54)
Nov 12, 2024	2024 (Q3)	1.25 / 1.59	1.57	1.27% (+0.02)
Aug 07, 2024	2024 (Q2)	1.00 / 1.56	1.88	-17.02% (-0.32)
May 07, 2024	2024 (Q1)	0.82 / 0.96	1.74	-44.83% (-0.78)
Feb 27, 2024	2023 (Q4)	1.19 / 1.57	1.6	-1.88% (-0.03)
Nov 06, 2023	2023 (Q3)	1.39 / 1.57	1.75	-10.29% (-0.18)
Aug 07, 2023	2023 (Q2)	1.60 / 1.88	1.37	37.23% (+0.51)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ICUI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$129.91	$112.85	-13.13%
May 08, 2025	$142.87	$138.30	-3.20%
Feb 27, 2025	$149.75	$146.33	-2.28%
Nov 12, 2024	$178.01	$174.81	-1.80%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Icu Medical (ICUI) report earnings?

Icu Medical (ICUI) is schdueled to report earning on Nov 10, 2025, After Close (Confirmed).

What is Icu Medical (ICUI) earnings time?

Icu Medical (ICUI) earnings time is at Nov 10, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ICUI EPS forecast?

ICUI EPS forecast for the fiscal quarter 2025 (Q3) is 1.43.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing